Search Results - "McGowan, Neil W A"
-
1
Generation of Functional Beta-Like Cells from Human Exocrine Pancreas
Published in PloS one (31-05-2016)“…Transcription factor mediated lineage reprogramming of human pancreatic exocrine tissue could conceivably provide an unlimited supply of islets for…”
Get full text
Journal Article -
2
Safety profile of autologous macrophage therapy for liver cirrhosis
Published in Nature medicine (01-10-2019)“…Therapies to reduce liver fibrosis and stimulate organ regeneration are urgently needed. We conducted a first-in-human, phase 1 dose-escalation trial of…”
Get full text
Journal Article -
3
Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activity
Published in Proceedings of the National Academy of Sciences - PNAS (20-07-2010)“…The neighbor of Brca1 gene (Nbr1) functions as an autophagy receptor involved in targeting ubiquitinated proteins for degradation. It also has a dual role as a…”
Get full text
Journal Article -
4
Human umbilical cord perivascular cells improve human pancreatic islet transplant function by increasing vascularization
Published in Science translational medicine (15-01-2020)“…Islet transplantation is an efficacious therapy for type 1 diabetes; however, islets from multiple donor pancreata are required, and a gradual attrition in…”
Get more information
Journal Article -
5
EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation
Published in Frontiers in immunology (01-07-2024)“…Adoptive immunotherapy with Epstein-Barr virus (EBV)-specific T cells is an effective treatment for relapsed or refractory EBV-induced post-transplant…”
Get full text
Journal Article -
6
Suppression of Epithelial-to-Mesenchymal Transitioning Enhances Ex Vivo Reprogramming of Human Exocrine Pancreatic Tissue Toward Functional Insulin-Producing β-Like Cells
Published in Diabetes (New York, N.Y.) (01-08-2013)“…Because of the lack of tissue available for islet transplantation, new sources of β-cells have been sought for the treatment of type 1 diabetes. The aim of…”
Get full text
Journal Article -
7
Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)
Published in BMJ open (08-11-2021)“…IntroductionLiver cirrhosis is a growing global healthcare challenge. Cirrhosis is characterised by severe liver fibrosis, organ dysfunction and complications…”
Get full text
Journal Article -
8
Islet transplantation from a nationally funded UK centre reaches socially deprived groups and improves metabolic outcomes
Published in Diabetologia (01-06-2015)“…Aims/hypothesis Type 1 diabetes complicated by hypoglycaemia is prevalent in socioeconomically deprived populations. Islet transplantation is of proven…”
Get full text
Journal Article -
9
Krüppel-Like Factor 4 Overexpression Initiates a Mesenchymal-to-Epithelial Transition and Redifferentiation of Human Pancreatic Cells following Expansion in Long Term Adherent Culture
Published in PloS one (12-10-2015)“…A replenishable source of insulin-producing cells has the potential to cure type 1 diabetes. Attempts to culture and expand pancreatic β-cells in vitro have…”
Get full text
Journal Article -
10
Binding Immunoglobulin Protein (BIP) Inhibits TNF‐α–Induced Osteoclast Differentiation and Systemic Bone Loss in an Erosive Arthritis Model
Published in ACR open rheumatology (01-08-2019)“…Objective The association between inflammation and dysregulated bone remodeling is apparent in rheumatoid arthritis and is recapitulated in the human tumor…”
Get full text
Journal Article -
11
Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis
Published in Cytotherapy (Oxford, England) (01-09-2017)“…Autologous macrophage therapy represents a potentially significant therapeutic advance for the treatment of severe progressive liver cirrhosis. Administration…”
Get full text
Journal Article -
12
Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions
Published in Cytotherapy (Oxford, England) (01-12-2020)“…Mesenchymal stromal cells (MSCs) isolated from various tissues are under investigation as cellular therapeutics in a wide range of diseases. It is appreciated…”
Get full text
Journal Article -
13
Good Manufacturing Practice (GMP) Translation of Advanced Cellular Therapeutics: Lessons for the Manufacture of Erythrocytes as Medicinal Products
Published in Methods in molecular biology (Clifton, N.J.) (01-01-2018)“…Blood transfusion is a mainstay of modern medical practice. In many parts of the world the use of this life-saving therapy is hampered by issues of supply and…”
Get more information
Journal Article -
14
Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study
Published in Cytotherapy (Oxford, England) (01-11-2015)“…Abstract Background aims Macrophages have complex roles in the liver. The aim of this study was to compare profiles of human monocyte-derived macrophages…”
Get full text
Journal Article -
15
Allogeneic Ex Vivo Expanded Corneal Epithelial Stem Cell Transplantation: A Randomized Controlled Clinical Trial
Published in Stem cells translational medicine (01-04-2019)“…Limbal stem cell deficiency (LSCD) is a disease resulting from the loss or dysfunction of epithelial stem cells, which seriously impairs sight. Autologous…”
Get full text
Journal Article -
16
Cytokine-Activated Endothelium Recruits Osteoclast Precursors
Published in Endocrinology (Philadelphia) (01-04-2001)“…Osteoclast precursors reach sites of osteoclast formation and remodelling via the vasculature and are therefore destined to encounter endothelium before…”
Get full text
Journal Article -
17
A Mutation Affecting the Latency-Associated Peptide of TGFβ1 in Camurati-Engelmann Disease Enhances Osteoclast Formation in Vitro
Published in The journal of clinical endocrinology and metabolism (01-07-2003)“…Camurati-Engelmann disease (CED) is a rare autosomal dominant disorder characterized by bone pain and osteosclerosis affecting the diaphysis of long bones. CED…”
Get full text
Journal Article -
18
Islet Activity and Outcomes in the United Kingdom
Published in Transplantation (27-09-2013)“…On 1 April 2008 an integrated national islet transplant programme was commissioned in the United Kingdom (UK) for treatment of recurrent life-threatening…”
Get full text
Journal Article -
19
Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing [beta]-like cells.(ORIGINAL ARTICLE)
Published in Diabetes (New York, N.Y.) (01-08-2013)“…Because of the lack of tissue available for islet transplantation, new sources of [beta]-cells have been sought for the treatment of type 1 diabetes. The aim…”
Get full text
Journal Article -
20
A mutation affecting the latency-associated peptide of TGFbeta1 in Camurati-Engelmann disease enhances osteoclast formation in vitro
Published in The journal of clinical endocrinology and metabolism (01-07-2003)“…Camurati-Engelmann disease (CED) is a rare autosomal dominant disorder characterized by bone pain and osteosclerosis affecting the diaphysis of long bones. CED…”
Get full text
Journal Article